TELA - TELA Bio Q2 GAAP EPS of -$0.88 revenue of $10.4M FY22 guidance in-line with consensus
- TELA Bio press release ( NASDAQ: TELA ): Q2 GAAP EPS of -$0.88 (vs. -$0.57 Y/Y).
- Revenue of $10.4M (+37.6% Y/Y).
- FY22 revenue expected to be in the range from $42M to $45M (vs. consensus of $42.27M)
For further details see:
TELA Bio Q2 GAAP EPS of -$0.88, revenue of $10.4M, FY22 guidance in-line with consensus